Why Trump Can Boost Biotech ETFs
In the months leading up to last week's presidential election, it was clear that perhaps no other sector and the relevant ETFs were caught in political crossfire on par with biotechnology. The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), which tracks the Nasdaq Biotechnology Index, and rival biotechnology exchange traded funds were stung by campaign trail… Click to read more at ETFtrends.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
This article was provided by our partner Tom Lydon of etftrends.com.